TVS Srichakra Q2 FY27: cons. PAT up 305% YoY to ₹44.4 Cr as margins expand to 3.5%
PAT +305.38% YoY · revenue +37.36% · margins expanding · beat vs street
₹1,272.63 Cr
+37.36% YoY
₹44.43 Cr
+305.38% YoY
3.48%
+2.3pp YoY
₹58.02
TVS Srichakra's consolidated Q2 FY27 (quarter ended September 30, 2026) revenue rose 37.4% YoY to ₹1,272.63 Cr (₹926.49 Cr) and 19.2% QoQ (₹1,067.61 Cr), while PAT more than quadrupled YoY to ₹44.43 Cr from ₹10.96 Cr, up 30.6% QoQ from ₹34.02 Cr in Q1 FY27. Both figures beat our pre-result preview, which had pencilled in consolidated revenue of ~₹1,100 Cr and PAT of ~₹28-32 Cr on the back of Q1's 165% PAT growth — the company not only sustained Q1's margin recovery but extended it, directly answering the preview's framing question ('Can Srichakra Sustain Q1's Margin Surge?') in the affirmative. There is no formal management guidance on record for this result, so the only external yardstick available is the Street/preview comparison, which the print cleared comfortably.
Q2 FY-2027 vs prior quarters
The growth was margin-led: consolidated net profit margin expanded to 3.48% from 1.18% a year ago and 3.14% last quarter, while computed EBITDA margin (EBITDA/revenue) rose to roughly 8.2% from about 6.8% in Q2 FY26 and 7.5-7.6% in Q1 FY27. This came even as cost of materials consumed rose 58.7% YoY to ₹773.31 Cr — faster than the 37.4% revenue growth — offset by scale benefits in employee costs (up only 10% YoY to ₹119.57 Cr) and other expenses (up 34.4% YoY to ₹269.59 Cr), consistent with operating leverage rather than a one-off cost tailwind. Both periods carried a VRS exceptional charge — ₹0.69 Cr this quarter versus ₹2.56 Cr a year ago — so if anything the prior-year base was more burdened by one-offs; stripping these from both sides still leaves adjusted YoY PAT growth above 200%, confirming the headline number reflects genuine operating improvement.
The stock went into the print at ₹4,348, up 0.4% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.
Standalone PAT of ₹34.55 Cr trailed consolidated PAT of ₹44.43 Cr by about ₹9.9 Cr, with the gap coming from the five subsidiaries — principally the Eurogrip export/retail push (the quarter saw EICMA/SEMA showcases and a Diwali brand campaign) and US subsidiary Super Grip Corporation. The company continues to carry a ₹7.21 Cr receivable against US IEEPA tariff refunds, with management assessing no impairment required as of quarter-end. No management press release accompanying the results was available to corroborate management's own framing. Two capital-allocation events fall just after the quarter-end and are therefore not reflected in these numbers: a ₹34.44 Cr realisation from TASL's capital reduction (October 8) and a ₹49.20 Cr capacity-expansion investment (October 17), alongside a minor ₹10.71 lakh GST penalty (October 6).
W1
Whether the ~8.2% operating margin holds into H2 FY27 against a flattish raw-material outlook, per the preview's central question
W2
Resolution/utilisation of the ₹7.21 Cr IEEPA tariff refund receivable amid ongoing US tariff legal developments
W3
Deployment and payback of the ₹49.20 Cr capacity-expansion investment (announced Oct 17) on future volumes
Clean digital filing, columns unambiguous, all arithmetic ties exactly. Both periods carry a modest VRS exceptional cost (₹0.69 Cr now vs ₹2.56 Cr YoY); newly-acquired 51%-owned Weber Drivetrain (from 31-Aug-26) contributed immaterial ₹0.01 Cr PAT and is unreviewed by its auditor per the review report.
Can Srichakra Sustain Q1's Margin Surge?
TVS Srichakra enters Q2 on the back of an exceptional Q1 showing 165% PAT growth. The Street watches whether that margin recovery sticks—or retreats—as the tyre sector faces a flattish raw-material outlook and rising scale needs.
The Setup: Margin Recovery on Trial
TVS Srichakra reported an exceptional Q1 FY27—consolidated revenue ₹1,067.6 Cr (up 30.3% YoY) and consolidated PAT ₹34 Cr (up 165% YoY). That margin surge was the headline. Q2 is the follow-through test: did the company lock in gains from product mix, operational leverage, and raw-material tailwinds, or was Q1 an outlier? The Street's consensus—15–20% PAT growth for FY27 as a whole—implies a moderation from Q1's 165%, but still robust. The framing for Q2: is Srichakra on track to deliver that FY27 consensus?
~₹1,100 Cr
30% YoY growth in Q1; sector growth 7–8% on replacement demand; volumes tracking healthy
~₹28–32 Cr
Q1 was ₹34 Cr (165% YoY). Steady 15–20% FY27 growth (Street consensus) implies moderation but still strong
Watch closely
Raw-material outlook flattish in Q2; any softness in commodities vs. Q1 will be key. Festive-season demand tailwind expected
Growth sustained?
Auto sector Q2 saw 10% volume growth; two-wheeler and three-wheeler tyres track closely. Eurogrip product launches signal confidence
What Strong vs. Weak Looks Like
Strong Q2: Revenue in line with 25–30% YoY growth, PAT shows sustainable margin hold vs. Q1 (even if % growth is lower), EBITDA margin north of Q1 levels or flat, and management commentary on FY27 full-year guidance intact or raised. Eurogrip product launches and export momentum gain traction; capex plans remain on track. Weak Q2: Revenue growth drops below 20% YoY (signalling demand loss or mix shift), PAT misses expectations by >10%, margin compression vs. Q1, or management walks back FY27 guidance. Capex delays, competitive price pressure in tyres, or supply-chain headwinds surface.
On Track for Full-Year Guidance?
No explicit FY27 PAT or revenue guidance has been disclosed; however, the Street consensus of 15–20% PAT growth for FY27 (from ₹205 Cr estimated FY26 base, implying ~₹237–₹246 Cr FY27) anchors expectations. Q1's 165% YoY was an exceptional outlier, likely driven by margin recovery from commodity tailwinds, mix uplift, and operational leverage. For Srichakra to hit the Street's 15–20% consensus, Q2–Q4 PAT must average ~₹26–₹31 Cr per quarter—a step down from Q1 but still healthy. The capex spend of ₹49.20 Cr (announced Oct 17) for capacity expansion at Madurai and Uttarakhand signals management confidence in the volume trajectory and willingness to invest ahead of demand. That's constructive for sustained growth, though execution risk remains.
What the Street Says
Since Last Quarter: The Filings Scan
Oct 17
—₹49.20 Cr capex for line balancing, debottlenecking, curing capacity at Madurai & Uttarakhand
Oct 8
—Realized ₹34.44 Cr from TASL Automobile capital reduction (promoter group investment exit)
Sep 29
—₹17.53 Cr tax show-cause notice for excess ITC availment (AY 2022-23, Deputy Commissioner, Mumbai)
Sep 28
—Trading window closed for Q2 FY27 results (SEBI insider-trading compliance)
Sep 25
—Two new Eurogrip retail outlets in UP & Uttarakhand (21st new store expansion)
Sep 3
—TVS Sensing Solutions acquired 51% of Weber Drivetrain (step-down subsidiary move)
Nov 5
—Eurogrip launches Protorq Max (SuperSport tyre) and Bee Sport at EICMA 2026 & SEMA 2026
Nov 10
—Eurogrip Diwali film 'Worth the Wait' released (brand visibility push)
The Watch List
1 · EBITDA margin & PAT trajectory
Is Q1's 3.2% PAT margin sustained, improving, or retreating? Commodity costs are the swing factor. Management commentary on H2 margin outlook will make or break investor confidence.
2 · Volumes & revenue mix
Track 2-wheeler, 3-wheeler, and industrial tyre growth separately. Eurogrip export and premium-product mix (SuperSport, Protorq) will signal whether pricing power and higher-margin segments are gaining. Q2 auto sector saw 10% volume growth; did TVS capture share?
3 · Tax contingency update & capex burn
Clarify the ₹17.53 Cr ITC notice—is it under appeal, provisioned, or contingent? Also, provide capex execution update on the ₹49.20 Cr announced spend. Working capital trends matter too in a high-commodity-cost environment.
The Bottom Line
TVS Srichakra enters Q2 riding the momentum of a 165% PAT surge in Q1, but that was exceptional. The real story for Q2 is whether the company's operational improvements, mix shift, and commodity tailwinds can translate into sustained, profitable growth that justifies the Street's 15–20% FY27 PAT growth consensus and ₹5,000 target. At current ₹4,302, the stock reflects a steady-but-not-spectacular outlook—gains are priced in, but so is execution risk.
Watch revenue growth (should stay 25%+ YoY to track Q1 momentum), margin hold (EBITDA and PAT—any compression is a red flag), and management's tone on capex and FY27 full-year guidance. The tax show-cause notice is a governance watch; resolution or provisioning clarity will matter for investor confidence. Eurogrip's international footprint and premium-tyre launches are positives, but they need to show up in the numbers—not just in press releases.